HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

SCH 530348

has antiplatelet activity; structure in first source
Also Known As:
SCH-530348; SCH530348
Networked: 25 relevant articles (3 outcomes, 16 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bonaca, Marc P: 5 articles (12/2014 - 09/2009)
2. Morrow, David A: 5 articles (12/2014 - 09/2009)
3. Braunwald, Eugene: 4 articles (12/2014 - 09/2009)
4. Scirica, Benjamin M: 4 articles (12/2014 - 09/2009)
5. Murphy, Sabina A: 3 articles (12/2014 - 04/2013)
6. Goto, Shinya: 3 articles (12/2014 - 02/2010)
7. Strony, John: 3 articles (03/2014 - 03/2009)
8. Wiviott, Stephen D: 2 articles (12/2014 - 12/2014)
9. Harrington, Robert A: 2 articles (03/2014 - 03/2009)
10. Moliterno, David J: 2 articles (03/2014 - 03/2009)

Related Diseases

1. Acute Coronary Syndrome
2. Stroke (Strokes)
3. Hemorrhage
4. Atherosclerosis
5. Myocardial Infarction

Related Drugs and Biologics

1. Thrombin Receptors (Thrombin Receptor)
2. Aspirin (Acetylsalicylic Acid)
3. Thrombin
4. clopidogrel (Plavix)
5. Purinergic P2 Receptors (ADP Receptor)
6. omega-Chloroacetophenone (Mace)
7. PAR-1 Receptor
8. Platelet Aggregation Inhibitors (Antiplatelet Drugs)
9. Matrix Metalloproteinase 9 (Gelatinase B)
10. Simvastatin (Zocor)

Related Therapies and Procedures

1. Stents